Uk Drug Regulator
- All
- News
- Videos
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
UK Approves An Updated Moderna Vaccine Which Targets Omicron Variant
The UK's drug regulator said Monday it has approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.
-
UK Approves GlaxoSmithKline Drug, Appears Effective Against Omicron
British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it "retains activity" against the new Omicron variant.
-
Serum Institute Seeks India Trial Of A Second Covid Vaccine
The Serum Institute of India, the world's biggest vaccine makers, has sought the drug regulator's permission to conduct a small domestic trial of the Novavax Inc COVID-19 vaccine that was found to be 89.3% effective in a UK trial, its CEO told Reuters on Friday.
-
Oxford Vaccine Likely To Be First To Get Approval In India, Say Officials
With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week, before deciding on giving emergency use authorisation to the Serum Institute that is manufacturing the shots.
-
Oxford-AstraZeneca Covid Vaccine Submitted For UK Approval
The University of Oxford and drug manufacturer AstraZeneca have applied to the UK health regulator for permission to roll out their Covid-19 vaccine, Health Minister Matt Hancock said Wednesday.
-
UK Asks Regulator To Study AstraZeneca Vaccine
The British government said on Friday it has asked its independent medicines regulator to assess AstraZeneca's coronavirus vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.
-
UK Suspends Hydroxychloroquine Trial For COVID-19
Britain's drug regulator on Tuesday instructed scientists trialling the use of malaria drug hydroxychloroquine for the treatment or prevention of COVID-19 to suspend the recruitment of participants.
-
India Drug Regulator Allows Serum Insititute To Export Its Malaria Vaccine To UK
India's drug regulator has allowed the export of the first produced-in-India vaccine against malaria, developed by scientists at the University of Oxford and manufactured by Serum Institute to the UK.
-
UK Approves An Updated Moderna Vaccine Which Targets Omicron Variant
The UK's drug regulator said Monday it has approved an updated Moderna vaccine against the coronavirus that targets the Omicron variant as well as the original form.
-
UK Approves GlaxoSmithKline Drug, Appears Effective Against Omicron
British regulators on Thursday approved GlaxoSmithKline drug sotrovimab to treat those at high risk of developing severe Covid-19 symptoms, with the manufacturer saying it "retains activity" against the new Omicron variant.
-
Serum Institute Seeks India Trial Of A Second Covid Vaccine
The Serum Institute of India, the world's biggest vaccine makers, has sought the drug regulator's permission to conduct a small domestic trial of the Novavax Inc COVID-19 vaccine that was found to be 89.3% effective in a UK trial, its CEO told Reuters on Friday.
-
Oxford Vaccine Likely To Be First To Get Approval In India, Say Officials
With preparations underway for a possible vaccine-rollout by January, the Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford COVID-19 vaccine next week, before deciding on giving emergency use authorisation to the Serum Institute that is manufacturing the shots.
-
Oxford-AstraZeneca Covid Vaccine Submitted For UK Approval
The University of Oxford and drug manufacturer AstraZeneca have applied to the UK health regulator for permission to roll out their Covid-19 vaccine, Health Minister Matt Hancock said Wednesday.
-
UK Asks Regulator To Study AstraZeneca Vaccine
The British government said on Friday it has asked its independent medicines regulator to assess AstraZeneca's coronavirus vaccine as part of the formal approval process for the drug to be rolled out by the end of the year.
-
UK Suspends Hydroxychloroquine Trial For COVID-19
Britain's drug regulator on Tuesday instructed scientists trialling the use of malaria drug hydroxychloroquine for the treatment or prevention of COVID-19 to suspend the recruitment of participants.
